Company: NIVFW
Filing Date: 2025-09-15
Form Type: F-1
Source: 0001213900-25-087717
Chunk: 142

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-15
Form: F-1
Chunk 142
---
 children, NewGenIvf offers mainly two services, namely: (i) IVF treatment service, comprising traditional IVF and egg donation; and (ii) surrogacy and ancillary caring services. The following table sets forth NewGenIvf’s revenue by service offerings and as a percentage of total revenue for the periods indicated:

|                                         |     | For the Year ended December 31, |      2024 |     |   |       |     |     |      2023 |     |   |       |
|:----------------------------------------|:----|:--------------------------------|----------:|:----|:--|------:|:----|:----|----------:|:----|:--|------:|
|                                         |     | US$                             |           |     | % |       |     | US$ |           |     | % |       |
| IVF Treatment Service                   |     |                                 | 5,433,375 |     |   | 100.0 |     |     | 4,021,696 |     |   |  78.3 |
| Surrogacy and Ancillary Caring Services |     |                                 |         — |     |   |     — |     |     | 1,114,457 |     |   |  21.7 |
| Total Revenue                           |     |                                 | 5,433,375 |     |   | 100.0 |     |     | 5,136,153 |     |   | 100.0 |

IVF Treatment Service NewGenIvf primarily provides its clients with conventional IVF/ICSI and embryo transfer services. NewGenIvf is also able to, through MicroSort technology, help fulfill the family-balancing dreams of its clients and avoiding certain gender-related hereditary diseases. IVF treatments that NewGenIvf provides address tubal factor, ovulatory dysfunction, diminished ovarian reserve, endometriosis, uterine factor, male factor, unexplained infertility and other causes. IVF bypasses the function of the fallopian tube by achieving fertilization within a laboratory environment. Ovarian hyper-stimulation is common with IVF treatments to recruit numerous follicles to increase the chances for success. Follicles are retrieved trans-vaginally using a vaginal probe and ultrasound guidance. Anaesthesia is frequently used due to the number of follicles retrieved and the resulting discomfort experienced by the patient. The eggs are identified in the follicular fluid and combined